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I
ntracerebral hemorrhage (ICH) accounts for 10% to 15% of strokes with a mortality rate greater than 40%. Many survivors are permanently disabled (1) . In experimental ICH animal models, neurologic deficits were associated with an increase in production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (2) , which damage the bloodbrain barrier (BBB) and increase brain edema (3, 4) . Hydrogen therapy neutralized ROS and diminished oxidative stress in several brain injury models (5) (6) (7) . However, the mechanism underlying the beneficial effects of hydrogen therapy remain poorly understood.
Mast cells are resident inflammatory cells that are present in various tissues including the central nervous system (8) . They contain granules with vasoactive substances such as histamine, proteolytic enzymes (tryptase), and anticoagulants (heparin). Mast cell activation and degranulation, which contribute to BBB disruption and increased bleeding (8) following brain injury, have been observed in several experimental models. In an autologous blood injection ICH model, mast cell stabilization reduced brain edema and improved neurologic deficits (9) . Similarly, mast-cell deficient animals had shown significantly less brain edema than wild type after ICH (9) . Mast cell activation was accompanied by increased ROS (10) and RNS (11) production. Hydrogen suppressed FcεR-mediated signal transduction and prevented degranulation of mast cells (12) .
Interestingly, activation of mast cells was accompanied by increased production of ROS (10) and RNS (11) , and hydrogen suppressed FcεR-mediated signal transduction and prevented degranulation of mast cells (12) . Therefore, we tested the hypothesis that firstly ICH produced mast cell activation by increased phosphorylation of Lyn kinase in the brain tissues. Activated mast cells degranulated, enhanced tryptase release, and augmented redox stress. Secondly, hydrogen inhalation diminished the phosphorylation of Lyn, which in turn decreased mast cell activation and redox stress. Thirdly, hydrogen inhalation preserved BBB integrity, decreased brain edema, and ameliorated neurologic deficits.
MATERIAL AND METHODS

Experimental Animals
All procedures and methods for these studies were approved by the Animal Care and Use Committee at Loma Linda University and complied with the Guide for the Care and Use of Laboratory Animals (animals protocol number 8100024). A total of 171 8-week-old male CD-1 mice were used.
Animals Group. Details are listed in the supplemental data (Supplemental Digital Content 1, http://links.lww.com/CCM/ A583).
Intracerebral Hemorrhage Induction. Experimental ICH was induced by intrastriatal injection of either bacterial collagenase or autologous blood as we previously described (13, 14) . Details are listed in the supplemental data (Supplemental Digital Content 1, http://links.lww.com/CCM/A583).
Hydrogen Inhalation Treatment. One hour after operation, animals were placed in a chamber connected to a hydrogen gas tank. The hydrogen treatment chamber was continually flushed with gas mix 2.9% hydrogen and 21% oxygen balanced with nitrogen, flow rate 8 L per minute. Hydrogen concentration was controlled at outlet using a Hydrogen meter (H 2 Scan, Valencia, CA). The chamber was warmed by using a warming path (37°C). No hydrogen toxicity was observed.
Vehicle (medical air inhalation) and sham (needle trauma, medical air inhalation) animals were placed in a chamber. The chamber was warmed and continually flushed with medical air (flow rate 8 L per min).
3-Amino-1,2,4-Triazole Treatment. 3-amino-1,2,4-triazole (AT) was purchased by Sigma Aldrich (St. Louis, MO). AT was dissolved in saline and administrated intraperitoneally 5 hours before ICH induction.
Evaluation of Brain Edema and Neurologic Deficits. The brain water content and neurologic deficits were evaluated as previously described (13) . Details are listed in the supplemental data (Supplemental Digital Content 1, http://links. lww.com/CCM/A583).
Evaluation of BBB Permeability (Evans Blue Assay) and Hematoma Volume (Hemoglobin Assay). BBB permeability and hematoma volume were evaluated as previously described (15) . Details are listed in the supplemental data (Supplemental Digital Content 1, http://links.lww.com/CCM/A583).
Western Blot Analysis. Mice were perfused transcardially with 40 mL of cold phosphate-buffered saline. Hemispheres were isolated and stored at -80°C until analysis. Protein extraction and Western blots were performed according to the manufacture recommendation as previously described (16 Statistically significant neurologic deficits were evident in all ICH versus sham-animals at 23 hours after collagenase injection as tested by the modified Garcia test (Fig. 1B) , wire hang, and beam balance tests (Fig. 1C) . A statistically significant improvement was seen in all three neurobehavioral assessments after 1 hour of hydrogen inhalation. Two hours of hydrogen inhalation led to statistically significant neurofunctional improvement in the wire hang and beam balance tests and showed a tendency to ameliorate neurologic deficits in the Garcia Test.
RESULTS
Effect of Hydrogen Inhalation on Brain Edema and
As 1 hour of hydrogen inhalation was effective at 24 hours after ICH, the effect of a single hydrogen treatment (starting 1 hr after ICH) was compared with multiple treatments (1 hr duration daily for 72 hr) and evaluated at 72 hours after ICH. 
Effect of Hydrogen on the Hematoma Volume-Hemoglobin Assay
One hour of hydrogen inhalation had no effect on hemorrhage volume at 24 or 72 hours (data not shown).
Effect of Hydrogen on BBB Permeability-Evans Blue Assay
Significant accumulation of Evans Blue stain was observed in the ipsilateral hemisphere of ICH compared with sham animals (9.11 ± 0.69 vs. 4.09 ± 0.14 μg of Evans Blue/g of tissue, p < 0.05, Fig. 2A) . One hour of hydrogen inhalation significantly decreased the amount of the stain in the ipsilateral hemisphere of hydrogen-treated compared with vehicle at 24 hours (7.20 ± 0.45 vs. 9.11 ± 0.69, p < 0.05, Fig. 2A ). However, 1 hour of hydrogen treatment demonstrated a nonsignificant tendency to preserve BBB at 72 hr (7.55 ± 0.76 vs. 6.50 ± 0.6, p = 0.30, Fig. 2B ).
Effect of ICH and Hydrogen on LYN Kinase Expression and Phosphorylation
Lyn expression and phosphorylation was evaluated 6 hours after ICH in both hydrogen-treated and untreated groups. Neither ICH nor hydrogen had an effect on LYN kinase expression (Fig. 3A) . However, ICH significantly induced Lyn phosphorylation in brain of ICH compared with sham animals. Hydrogen inhalation significantly reduced ICH-induced Lyn phosphorylation (Fig. 3B) . Catalase inhibition had no effect on Lyn expression (Fig. 3A , last column), but increased Lyn phosphorylation (Fig. 3B, last column) .
Effect of ICH and Hydrogen Inhalation on the Release of Mast Cells Specific Proteins, Mast Cells Accumulation and Degranulation
Significant tryptase release was observed 6 hours after ICH by Western blot analysis. One hour of hydrogen treatment significantly decreased tryptase release (Fig. 4) . Catalase inhibition reversed effect of hydrogen on tryptase release (Fig. 4 , last column). Similarly, ICH increased the amount of tryptase positive cells in the brains of ICH compared with shams animals, visualized by immunostaining against tryptase. Hydrogen inhalation ameliorated this effect (Fig. 5) .
Additionally, ICH increased mast cell accumulation at 6 hours after ICH, evaluated by Toluidine Blue (Fig. 6 autologous blood injection induced the release of proteins tryptase and chymase by mast cells. This release was evaluated by Western blot at 6 hours after ICH and demonstrated no significant difference between the two models (Fig. 7) .
Effect of ICH and Hydrogen Inhalation on the H 2 O 2 Production
We evaluated the effect of hydrogen inhalation on H 2 O 2 production after ICH. ICH significantly increased H 2 O 2 production as early as 2 hours after ICH insult. One hour of hydrogen inhalation significantly decreased ICH-induced H 2 O 2 production (Fig. 8) . Catalase inhibition 4 hours before hydrogen inhalation resulted in H 2 O 2 production augmentation compared with hydrogen-treated animals (Fig. 8, last column) .
Effect of Hydrogen on Nitrotyrosine Accumulation
Western blot examination demonstrated a significant increase of nitrotyrosine in brain tissue of ICH mice at 24 hours. One hour of hydrogen inhalation reduced ICH-induced accumulation of nitrotyrosine. The hydrogen inhalation tended to decrease nitrotyrosine accumulation at 72 hours (Fig. 9) .
Effect of Catalase Inhibitor, 3-Amino-1,2,4-Triazole on the Effects Induced by Hydrogen Treatment
Inhibition of catalase 4 hours before hydrogen inhalation resulted in H 2 O 2 production enhancement compared with hydrogen-treated animals (Fig. 8, last column) . The enhance of H 2 O 2 production had no effect on Lyn expression (Fig. 3A , last column) but resulted in increase of Lyn phosphorylation (Fig.  3B , last column) and reversed effect of hydrogen on tryptase release (Fig. 4, last column) .
DISCUSSION
We investigated hydrogen inhalation therapy's ability to ameliorate secondary brain injury after ICH in mice. ICH-induced mast cell accumulation and degranulation, which increased tryptase release and redox stress in the brain. Those molecular changes were accompanied with BBB disruption, brain edema, and neurologic deficits. Hydrogen inhalation diminished ICH-induced mast cell activation, which reduced redox stress, enhanced BBB preservation, and diminished neurologic deficits. This is the first study that investigated hydrogen inhalation therapy's effects on brain mast cell activation and brain injury after ICH.
Hydrogen selectively scavenges hydroxyl radicals (7), which are the dominant ROS causing DNA fragmentation, lipid oxidation, and protein nitrification. Several hemorrhagic stroke models investigated the neuroprotective effects of hydrogen therapy (5, 18, 19) . Those studies demonstrated that hydrogen therapy reduced ROS levels and postulated that its beneficial effects are linked to its antioxidative properties. However, pathways leading to diminished oxidative stress following hydrogen treatment remain to be elucidated. After ICH, ROS causes peroxidation of lipid-rich structures of BBB, resulting in life-threatening BBB disruption and vasogenic brain edema (20) (21) (22) . It has been recently established that hydrogen, along with its antioxidant property, is a biologically active, gaseous signaling molecule (12) . Iton et al demonstrated that hydrogen treatment attenuated mast cell activation (23) .
Mast cells are resident cells of several types of tissues including central nervous tissue. They are located perivascularly close to neurons (24) . Mast cells include granules that contain substances such as histamine, heparin, tryptase, and tumor necrosis factor-α (25) . Release of these substances may increase initial bleeding after ICH and contribute to ICHinduced BBB disruption. Mast cell activation is mediated by the high-affinity immunoglobulin epsilon (FceRI) receptor (26) . FceRI receptor stimulation results in downstream phosphorylation of Lyn (27) , a Src family kinase that regulates mast cell activation (23) . Itoh et al demonstrated that hydrogen had no effect on FceRI expression, but hydrogen compromised the initial steps of mast cell activation by reducing Lyn phosphorylation (12) . In the present study, we used a mixture of oxygen (21%), hydrogen (2.9%), and nitrogen, which is inflammable and safe to use. The neuroprotective effects of this hydrogen concentration after brain injury were demonstrated by others (15, 19, 28 ).
We observed that hydrogen inhalation ameliorated ICHinduced increase of brain water content and neurologic deficits at 24 hours. We were unable to demonstrate that hydrogen inhalation ameliorated ICH-induced brain injury and neurologic deficits at 72 hours even though a tendency was observed. In addition to brain water content, we evaluated BBB integrity by measurement of Evan Blue (13, 15, 16, 29) . We observed that hydrogen inhalation preserved BBB integrity at 24 hours after ICH and showed a tendency to protect BBB at 72 hours after ICH.
Mast cell activation after brain injury was observed in several experimental animal studies (30) (31) (32) (33) . Espositio at al reported that acute stress activated mast cells in the brains of animals without brain injury (34) . Acute stress increased BBB permeability in wild-type but not in mast cell deficient animals. Mast cell stabilization ameliorated stress-induced BBB disruption (34) . These results indicated that mast cells are critical in increasing BBB permeability. In an ICH model, Strbian et al demonstrated that mast cell degranulation inhibition by cromoglycate significantly decreased hematoma volume calculated from T2 MRI images at 24 hours post-ICH (9). Furthermore, hematoma volume was significantly decreased in mast-cell deficient animal than in wild type animals. Mast cell stabilization decreased brain swelling, although mast cell activation was not studied directly and cromoglycate was used before ICH induction (9) . In the present study, we showed that ICH increased mast cell activation. The mast cell activation was evaluated as a ratio of phosphorylated Lyn divided by unphosphorylated Lyn as well as by the release of mast cell-specific protein tryptase in the animals' brains (12, 35) . We observed that ICH significantly increased LYN phosphorylation and the We employed the collagenase model of ICH l in most experiments. One limitation of the model is the inherent inflammatory reaction caused by collagenase. To rule out collagenase as a factor in mast cell activation, we employed the autologous blood-injection ICH model and compared the release mast cell specific proteins, between both models. We did not observe a significant difference in the release and postulated that ICH was the causative factor in mast cell activation. Therefore, it was likely that hydrogen inhalation decreased ICH-induced up-regulation of tryptase, as shown by Western blot and immunostaining of tryptase positive cells. Additionally, hydrogen inhalation decreased ICH-induced mast cell degranulation by Toluidine Blue staining, as previously described (36) . In the brain of shamoperated and hydrogen-treated ICH animals, mast cells could be identified by their metachromatic cytoplasmatic granules, whereas in ICH untreated animals most mast cells lost some of the stain and had a "ghost" shape. Moreover, more mast cells were present in the brains of ICH-untreated animals when compared with sham-operated and ICH hydrogen-treated animals. This was in agreement with the other study demonstrating that mast cell stabilization has a beneficial effect after ICH (9).
It has been established that Lyn-mediated signaling pathway activation enhanced the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity in mast cells (37) . NADPH oxidase generates superoxide and is considered a main source of ROS in the blood vessels (38, 39) . By the use of knock out animals, we previously demonstrated that oxidative stress resulted from NADPH oxidase activation and significantly contributed to ICH-induced brain injury (40) . Hydrogen attenuated NADPH oxidase activity and consequently reduced H 2 O 2 production (12). We evaluated H 2 O 2 production by Amplex Red peroxidase assay as described previously (41, 42) . Hydrogen inhalation significantly reduced ICH-induced H 2 O 2 production. Furthermore there is evidence that rodents' mast cells produce nitric oxide (NO) (43) . Although NO is a weak oxidant, combinations of various NO redox forms induce severe BBB damage (44) . Nitrotyrosine, a product of tyrosine nitration, is a common NO-induced cell damage indicator. Nitrotyrosine accumulation after brain injury was reported by others and is regarded as redox stress marker (5, 19, 45) . We observed considerable nitrotyrosin accumulation in the brains of ICH-animals that became significantly reduced in hydrogen-treated animals. These findings were in concurrence with prior studies by our laboratory (Fig. 7C, white arrow) .
that demonstrated hydrogen inhalation's antioxidant effects in other hemorrhagic stroke models (5, 19) .
Because oxidative stress leads to BBB disruption, we investigated the effect of hydrogen inhalation on BBB integrity by measuring brain water content and analysis by Evans Blue assay. We demonstrated that decreased mast cell activation via hydrogen inhalation resulted in BBB preservation. This observation is similar to that of Strbian et al who demonstrated that pretreatment with a mast cell degranulation inhibitor ameliorated BBB disruption after ICH (9) . It is also similar to Zhan et al (19) , who demonstrated that hydrogen had a protective effect on BBB after subarachnoid hemorrhage. However, we were unable to demonstrate any effect of hydrogen inhalation on hematoma volume (9) To test this hypothesis we used 3-amino-1,2,4-triazole (AT), a catalase inhibitor and extremely potent enzyme that decomposes H 2 O 2 into water and oxygen (46, 47, 48) . Consistent with Vehicle n = 6) significantly increased the production of hydrogen peroxide evaluated by Amplex Red peroxidase assay at 2 hr after ICH, when compared with shamoperated animals ( Sham n = 6). One hour of hydrogen treatment significantly diminished ICH-induced production of H 2 O 2 ( n = 6) . Pretreatment with catalase inhibitor at 3 hr before inducing of ICH ( n = 6) reversed effect of hydrogen on the hydrogen peroxide production. * Significant vs. sham, # significant vs. vehicle, p < 0.05 analysis of variance (ANOVA), Tukey test. previous publications, we found that giving AT 3 hours before ICH reversed the protective effect of hydrogen treatment and led to accumulation of H 2 O 2 . AT-induced accumulation of H 2 O 2 suppressed phosphorylation of Lyn kinase and increased tryptase release, indicating that mast cells are a potential target for hydrogen therapy.
CONCLUSIONS
We concluded that ICH caused mast cell activation and degranulation. Mast cell activation enhanced the release of mast cell-specific proteins and production of reactive oxygen and nitrogen specie, which contributed to BBB disruption and brain edema. Hydrogen inhalation diminished redox stress and BBB disruption by reducing the mast cell activation and degranulation, which ameliorated ICH-induced brain edema increase and neurologic deficits in mice.
Hydrogen therapy is easy to use and proven to be neuroprotective. So far, there have been no reported side effects from the therapy. Further studies translating presented results into the clinical setting for ICH management are needed.
